Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Umbilical cord blood stem cell transplantation for hematological cancers and nonmalignant disorders in children. Lansdale: HAYES, Inc.. Directory Publication. 2013 Authors' conclusions Umbilical cord blood transplantation (UCBT) is an alternative source of hematopoietic stem and progenitor cells for patients with hematological diseases that may be cured by allogeneic stem cell transplantation (SCT). While the largest successful experience with UCBT has been in the treatment of patients with hematological malignancies (e.g., leukemia, lymphoma, myelodysplastic syndromes), it has also been used to treat patients with many other inherited and acquired conditions such as aplastic anemia, metabolic disorders and autoimmune diseases. Other graft sources for SCT include bone marrow and peripheral blood. Indexing Status Subject indexing assigned by CRD MeSH Child; Child, Preschool; Cord Blood Stem Cell Transplantations; Hematologic Neoplasms; Infant Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32014000376 Date abstract record published 19/02/2014 |